Shows
The UromigosEpisode 415: Uromigos Score 前立腺がん編日本と海外の違いはあるのか？mHSPCとmCRPCのUromigos Scoreについて激論！！2025-05-1244 minThe UromigosEpisode 414: Uromigos score en cáncer de próstata metastasico - más allá de las guías clínicasEdición especial en castellano con Alfonso Gómez de Liaño y Guillermo de Velasco. David Lorente da su visión sobre el nuevo Uromigos Score, que clasifica distintas opciones de tratamiento en varios escenarios de cáncer de próstata metastásico2025-05-1228 minThe UromigosEpisode 413: The Uromigos Score for Advanced Prostate CancerSilke and Chris joins us to discuss our latest 'Uromigos Score' in which experts score the value of treatments for advanced prostate cancer. Several interesting themes emerge.2025-05-1237 minThe UromigosEpisode 408: Uromigos Japan - European Delphi Study of mRCCについてdiscussion今月Eur Urol OncolにPublishされたヨーロッパのエキスパートによるmRCCのコンセンサスについて日本との違いについて深い議論をしました！！2025-04-2333 minThe UromigosEpisode 402: Uromigos en Espanol: Futuro del carcinoma de células renalesCristina Suárez analiza los próximos ensayos clínicos que podrían transformar el manejo del cáncer renal en los próximos años: nuevas combinaciones adyuvantes y estrategias perioperatorias, el uso de tripletes enprimera línea y la integración de inhibidores de HIF con TKIs, entre otros.2025-03-3125 minThe UromigosEpisode 400: The Uromigos Score for Urothelial CancerLive from the Canary Islands 'Big Idea' talk from Tom, we discuss the new Uromigos Score which ranks different treatment options in several urothelial cancer settings.2025-03-2820 minThe UromigosEpisode 396: Uromigos Japan - 激論 @JSMO25尿路上皮癌と腎癌の臨床に影響を与えるエビデンスをどう解釈するか!?2025-03-0929 minThe UromigosEpisode 395: Uromigos Japan: ASCO GU 2025のレビューASCOGU2025で発表された臨床試験の結果の解釈について忖度なしに議論しました！！2025-03-0331 minThe UromigosEpisode 382: Uromigos Japan - TROPICs-04の考察残念ながらNegative StudyとなったTROPICs-04についてUromigos
Japanの3人が忖度なしに、その原因や理由について考察をします！！2025-02-0529 minThe UromigosEpisode 379: Uromigos Japan: 2024年のGU Oncologyを振り返る3人による2024年のGU oncoloyのレビューを切れ味鋭く解説しています。乞うご期待！
2025-01-1031 minThe UromigosEpisode 359: #UromigosLive24 - IO after IO in RCCThe RCC panel at Uromigos Live 2024 discusses and debates this topic.2024-10-0940 minThe UromigosEpisode 358: Noticias del Dia 1 de Uromigos Live 2024 en Nashville
En
este podcast cubrimos los temas de cáncer urotelial discutidos por los Uromigos. El impacto del estudio NIAGARA en utiliar quimio más inmunoterapia en
neadyuvancia de Ca urotelial músculo invasor, el uso de pembrolizumab adyuvante después de los datos del estudio AMBASSADOR y la búsqueda de biomarcadores.
2024-09-3021 minThe UromigosEpisode 355: #UromigosLive24 - Radioligands in prostate cancerThe Uromigos Live 2024 panel discusses recent radioligand data including PEACE-32024-09-2854 minThe UromigosEpisode 354: #UromigosLive24 - T cell directed therapy in prostate cancerBrian hosts a panel at Uromigos Live 2024 in Nashville with Michael Morris, Tanya Dorff and Karen Autio2024-09-2844 minThe UromigosEpisode 349: ESMO 2024 - Uromigos Japan!!Uromigos Japan with Yuji, Hiroshi and Nobu is formed and discuss Hiroshi's ESMO data.2024-09-1630 minThe UromigosEpisode 333: The Uromigos Cup - The NetherlandsAxel Bex, Christian Blank, Laura Mertens and Micheil Van der Heijden answer a range of relevant and sometimes irrelevant questions2024-07-0526 minThe UromigosEpisode 332: The Uromigos Cup - Germany's EntryViktor Gruenwald, Boris Hadaschik and Gunhild Von Amsberg answer questions around GU cancer and German football2024-06-2635 minThe UromigosEpisode 329: Japan in the Uromigos Cup qualifying roundNobuaki Matsubara, Hiroshi Kitamura and Yuji Miura battle through the sometimes ridiculous questions set by Tom and Brian.2024-06-0830 minThe UromigosEpisode 320: Team Canada's entry for the Uromigos CupDanny Heng, Christian Kollmannsberger and Kala Sridhar answer questions in an attempt to get to Nashville and take on LA to win the Uromigos Cup.2024-05-2523 minThe UromigosEpisode 311: The Uromigos Paper of the Month - The POUT TrialAlison Birtle describes adjuvant chemotherapy in bladder cancer. 2024-04-2336 minThe UromigosEpisode 306: The Uromigos Paper of the Month - Chemo/Nivo as a bladder sparing approach in UCMatt Galsky describes his phase 2 study looking at gem/cis/nivo followed by nivo in responders. This potentially avoids cystectomy.2024-03-2829 minThe UromigosEpisode 289: The Uromigos Paper of the Month - TALAPRO2 in Nature MedicineKarim Fizazi discusses the clinical and biomarker components of this data.2024-01-1536 minThe UromigosEpisode 281: The Uromigos Paper of the Month - Lu-177 with Pembrolizumab in Prostate CancerRahul Aggarwal describes his phase 1/2 study with only 1 cycle of Lu-177 in CRPC. 2023-12-0825 minThe UromigosAn apologyTom and Brian apologise for the unacceptable words and images which were broadcast by hackers during the Uromigos livestream last week. We’re really sorry and will do everything we can to make sure it never happens again.2023-11-1401 minThe UromigosEpisode 279: Management of IO-resistant RCC at #UromigosLive 2023Monty Pal, Toni Chouieri, and Tian Zhang join Tom and Brian to discuss CONTACT-03, TiNivo-2, IO-based therapy, and more.
Recorded live at Uromigos Live & Unplugged 2023 in Nashville, TN.2023-11-061h 00The UromigosEpisode 278: Current and Future Status of Radioligand Therapy at #UromigosLive 2023Brian is joined by Neeraj Agarwal, Tanya Dorff, Rana McKay, and Michael Morris to review the state of radioligand therapy. The panel examines primary and secondary end points of VISION, current practice patterns, the right way to dose 177Lu-PSMA, PSMAfore, and more.
Recorded live at Uromigos Live & Unplugged 2023 in Nashville, TN.2023-11-0439 minThe UromigosEpisode 277: NMIBC Discussion at #UromigosLive 2023Tom is joined by Sam Chang, Sia Daneshmand, and Petros Grivas to discuss new therapies in non-muscle invasive bladder cancer, including those for BCG-refractory NMIBC and the cretostimogene + pembrolizumab combo for BCG-unresponsive NMIBC.
Recorded live at Uromigos Live & Unplugged 2023 in Nashville, TN.2023-11-0444 minThe UromigosEpisode 226: 2023 ASCO GU Prostate and RCC Highlights With Dan GeorgeThe Uromigos are joined by Daniel George, MD, to review RCC and prostate cancer presentations from the 2023 ASCO GU Cancers Symposium, including triplet versus doublet therapy, the ARASENS trial, and the ZIRCON phase 3 trial. Dr. George is a medical oncologist at Duke Health, specializing in genitourinary malignancies.
2023-02-2725 minThe UromigosEpisode 224: ASCO GU 2023: discussing miR371 for Germ Cell Tumors with Christian KollmannsbergerThe Uromigos are joined by Christian Kollmannsberger, MD, FRCPC, to discuss his presentation at the ASCO GU Cancers Symposium on utilizing miR371 as a biomarker for germ cell tumors to help optimize patient management by improving decision-making. Dr. Kollmannsberger is a medical oncologist at the British Columbia Cancer Agency Vancouver Cancer Centre, and Clinical Professor at the University of British Columbia.2023-02-2027 minThe UromigosEpisode 223: ASCO GU 2023: Discussing KEYNOTE-057 with Andrea Necchi, MDThe Uromigos met with Andrea Necchi, MD at the 2023 ASCO GU Cancers Symposium to discuss results of the phase 2 KEYNOTE-057 study on the use of pembrolizumab monotherapy for patients with high-risk non-muscle-invasive bladder cancer who are unresponsive to bacillus Calmette–Guérin therapy. Dr. Necchi is an Associate Professor at Università Vita-Salute San Raffaele, Head of Genitourinary Medical Oncology at Ospedale San Raffaele, and Vice President of the Global Society of Rare GU Tumors.2023-02-1724 minThe UromigosEpisode 222: ASCO GU 2023: New Data From IMvigor130 with Enrique Grande, MDEnrique Grande, MD, PhD, Msc, met with The Uromigos at the 2023 ASCO GU Cancers Symposium to discuss the phase 3 IMvigor130 study that examined 3 treatments for patients with metastatic urothelial carcinoma: chemotherapy, single-agent atezolizumab, or a combination treatment of atezolizumab plus chemotherapy. Dr. Grande is Director of the Medical Oncology Program and Clinical Research lead at the MD Anderson Cancer Center Madrid.2023-02-1720 minThe UromigosEpisode 220: ASCO GU 2023: Discussing PARPi for CRPC with Michael Morris, MDThe Uromigos met with Michael Morris, MD while at the 2023 ASCO GU Cancers Symposium to discuss PARP inhibition for castration-resistant prostate cancer and the differing opinions on how and when it should be utilized. Dr. Morris is a prostate cancer specialist and researcher, and the Prostate Cancer Section Head at Memorial Sloan Kettering Cancer Center.2023-02-1725 minThe UromigosEpisode 218: Discussing The Cost of Cancer Drugs With Daniel Goldstein, MDThe Uromigos discuss the cost of quality adjusted life years with Daniel Goldstein, MD, Senior Physician at the Davidoff Cancer Center of Rabin Medical Center. Dr. Goldstein specializes in the treatment of prostate, bladder, kidney and testicular cancers.2023-02-0725 minThe UromigosEpisode 216: ADCs in Bladder Cancer With Petros Grivas, MD, PhDPetros Grivas, MD, PhD joins The Uromigos to discuss the use of antibody drug conjugates in bladder cancer, including enfortumab vedotin (EV) and the results of the drug's EV-301 trial. The combination treatment of EV and pembrolizumab versus chemotherapy alone is also discussed, including the EV-302 trial. Dr. Grivas is a professor in the Division of Medical Oncology at the University of Washington School of Medicine, as well as a physician at Fred Hutch Cancer Center.2023-01-3025 minThe UromigosEpisode 202: The Uromigos Paper of the Month - Docetaxel with or without continuous enza in CRPCAxel Merseburger describes the results of this randomised trial in Lancet Oncology. 2022-11-0723 minThe UromigosEpisode 199: The Uromigos Paper of the Month - FGFR inhibition in bladder cancerRandomised trial of rogaratinib in bladder cancer with Cora Sternberg. 2022-10-1724 minThe UromigosEpisode 197: The Uromigos Nashville 2022Here are the details for the Livestream portions of The Uromigos Nashville meeting!
Bladder Cancel Panel on September 30, 1-2PM CST https://youtu.be/yzYkYZbCguE
Prostate Cancer on October 1, 10-11AM CST https://youtu.be/WghMP5kcqxQ
RCC Panel on October 1, 2-3PM CST https://youtu.be/4-DQ6lghQ2o2022-09-2909 minThe UromigosEpisode 189: The Uromigos Paper of the Month - Robotic vs open cystectomyJohn Kelly describes the benefits of robotic surgery.2022-08-2223 minThe UromigosEpisode 188: The 1st Uromigos Live and Unplugged face-to-face meetingAnnouncing The Uromigos Unplugged, taking place in Nashville from 29th-30th September. 2022-08-1523 minThe UromigosEpisode 187: Cora Sternberg - The Uromigos Legends SeriesCora Sternberg discusses her career in the next episode of the Legends series. 2022-08-1532 minThe UromigosEpisode 186: Bernard Escudier - The Uromigos Legends SeriesBernard Escudier discusses his career development and work in kidney cancer.2022-08-1025 minThe UromigosEpisode 185: The Uromigos Paper of the Month - ctDNA in prostate cancerAlex Wyatt describes this Nature paper. 2022-08-0125 minThe UromigosEpisode 183: Oliver Sartor - The Uromigos Legends SeriesOliver Sartor discusses his career development and work in prostate cancer. 2022-07-1827 min
The UromigosEpisode 169: The Uromigos Paper of the Month - Novel neoadjuvant approaches in UCSyed Hussein and Sam Funt describe their studies.2022-05-0924 minThe UromigosEpisode 163: The Uromigos Debate - Treatment of favorable risk renal cancerDavid McDermott attempts to get his point across...again. 2022-03-2134 minThe UromigosEpisode 152: The Uromigos Paper of the Month - Zr-Pembrolizumab PET ImagingElizabeth de Vries describes her paper in Annals of Oncology. 2022-02-0721 minThe UromigosEpisode 148: The Uromigos Paper of the Month - Stereotactic radiotherapy for advanced renal cancerChad Tang discusses his recent Lancet oncology paper. 2021-12-2127 minThe UromigosEpisode 143: The Uromigos Paper of the Month - Determinants of anti- PD-1 response and resistance in clear cell renal cell carcinomaSamra Turajlic describes her cancer cell paper. 2021-11-1728 minThe UromigosEpisode 142: Un resumen de la reciente reunión de Uromigos en CanariasAlfonso Gómez & Guillermo de Velasco describir los aspectos más destacados de esta reunión en español2021-11-1314 minThe UromigosEpisode 139: The Uromigos Paper of the Month - Talazoparib in biomarker positive prostate cancerTanya Dorff discusses this paper and the role of PARP inhibitors in prostate cancer. 2021-10-2723 minThe UromigosEpisode 130: Larry Einhorn - The Uromigos Legends in GU Cancer seriesLarry Einhorn describes the spectacular advances in testis cancer. 2021-09-0633 minThe UromigosEpisode 129: Phil Kantoff - The Uromigos Legends in GU Cancer seriesPhil discusses his career progression and prostate cancer. 2021-09-0231 minThe UromigosEpisode 125: The Uromigos Paper of the Month - MRI screening for prostate cancerMartin Ekland discusses his NEJM and Lancet Oncology papers. 2021-08-2728 minThe UromigosEpisode 124: Dean Bajorin - The Uromigos Legends in GU Cancer seriesDean Bajorin discusses developments in bladder and collaboration in testis cancer. 2021-08-2333 minThe UromigosEpisode 123: Maha Hussain - The Uromigos Legends in GU Cancer seriesMaha discusses her career in GU cancer with a focus on prostate cancer. 2021-08-2030 minThe UromigosEpisode 122: Nick Vogelzang - The Uromigos Legends in GU Cancer seriesNick discusses his career and describes treatment advances in RCC. 2021-08-1632 minThe UromigosEpisode 121: Conflicts of Interest with the podcastsTom, Brian and Chris discuss developments for Uromigos podcasts and growth for the future. 2021-08-0416 minThe UromigosEpisode 120: The Uromigos Paper of the Month from MallorcaZeynep Zengin describes ctDNA in renal cancer published in CCR this month. 2021-07-2921 minThe UromigosEpisode 101: The Uromigos Paper of the Month - Belzutifan in renal cancerEric Jonasch gives an overview of the recent Nature Medicine publication. 2021-05-2626 minThe UromigosEpisode 100: The Uromigos 100th Podcast - Looking to the FutureChris Sweeney, Kala Sridhar and David McDermott discuss the future. 2021-05-2136 minThe UromigosEpisode 93: The Uromigos Paper of the Month - A new risk classification for germ cell cancerSilke Gillessen discusses the back to back JCO papers on this topic. 2021-04-1423 minThe UromigosEpisode 91: The Uromigos Paper of the Month - Adjuvant atezolizumab in bladder cancerJoaquim Bellmunt describes this study as well as adjuvant nivolumab and ctDNA in bladder cancer. 2021-03-2629 minThe UromigosEpisode 90: The Uromigos Podcast with QOL Expert David CellaEverything you wanted to know about quality of life assessment in cancer but were too afraid to ask. 2021-03-1227 minThe UromigosEpisode 89: The Uromigos Paper of the Month - Pembrolizumab in clear cell and non-clear cell renal cancerDavid McDermott describes these back to back JCO publications. 2021-03-0428 minThe UromigosEpisode 77: The Uromigos Paper of the Month - Nadofaragene for BCG unresponsive NMIBCStephen Boorjian outlines his recent Lancet oncology paper.
Tom and Brian struggle to keep up. 2021-02-0617 minThe UromigosEpisode 75: The Uromigos meet APCCC - bone health and bone disease in prostate cancer with Bertrand TombalSilke, Chris and Bertrand discuss bone protective therapy and bone targeted therapy. 2021-01-1425 minThe UromigosEpisode 74: The Uromigos meet APCCC Round 2: First line treatment - low vs high volume; chemo vs abi/enzaNick James and Chris Sweeney debate this issue. Tom and Silke try to keep things on track. 2021-01-1132 minThe UromigosEpisode 73: The Uromigos meet APCCC in a discussion on oligometastatic prostate cancer @APCCC_LuganoPiet Ost, Chris Sweeney and Silke Gillessen discuss controversies around the management of oligometastatic prostate cancer. 2021-01-0825 minThe UromigosEpisode 72: Uromigos Christmas Special - Renal cancer year in reviewLaurence Albiges discusses renal cancer highlights from the year. 2020-12-2124 minThe UromigosEpisode 71: Bladder Cancer Uromigos Christmas Special with Matt GalskyMatt discusses the year in review, including first line and adjuvant immune therapy studies, ADCs and FGFR targeting are also discussed. 2020-12-1824 minThe UromigosEpisode 70: The Uromigos Prostate Cancer Christmas Special with Chuck RyanA review of the year in prostate cancer with Chuck Ryan. 2020-12-1125 minThe UromigosEpisode 68: Uromigos Paper of the Month - a molecular classification of renal cancer in Cancer CellKim Rathmell discusses this paper, which divides clear cell renal cancer into seven relevant subgroups. Brian askes an interesting question at one point. 2020-12-0826 minThe UromigosEpisode 67: The Third Uromigos Debate - PD1/VEGF vs PD1/CTLA4 for front line renal cancerDavid McDermott and Brian Rini debate treatment options in front line renal cancer. It's hard to identify any winners from this podcast.2020-11-1728 minThe UromigosEpisode 66: Uromigos Paper of the Month - Two papers in Nature Medicine on neoadjuvant immune combinations in bladder cancerPam Sharma and Michiel Van Der Heijden discuss neoadjuvant PD(L)1 + CTLA4 inhibition in urothelial cancer. 2020-11-0930 minThe UromigosEpisode 64: The Second Uromigos debate with Nobel Laureate Bill Kaelin on new biomarker vs new drugs in RCC'New Drugs vs New Biomarkers' Bill Kaelin (Nobel Laureate) vs Tom Powles (keen cyclist), extend their discussion from KCRS20 in the 2nd Uromigos Debate. 2020-10-2828 minThe UromigosEpisode 63: The First Uromigos Debate: front line immune therapy vs maintenance avelumab in bladder cancerDr. Peter O'Donnell and Prof. Tom Powles debate front line treatment options in urothelial cancer. 2020-10-0921 minThe UromigosEpisode 62: James Eastham's Uromigos Paper of the Month - Prostatectomy +/- Neoadjuvant ChemoA large randomised investigator-initiated Alliance study gives insight in to perioperative treatments for high risk prostate cancer. 2020-10-0627 minThe UromigosEpisode 61: Nick James discusses the latest update of the STAMPEDE studyNick gives us a quick summary of the STAMPEDE study and gives an overview of the latest data. 2020-09-2117 minThe UromigosEpisode 60: Cora Sternberg discusses AMG 160 - a bispecific antibody in prostate cancerAMG 160; a half-life extended (HLE) bispecific T-cell engager (BITE®) antibody construct is discussed as is the future of immune therapy in CRPC. 2020-09-2114 minThe UromigosEpisode 59: Ipatercertib in biomarker positive castrate resistant prostate cancerChris Sweeney (last author) discusses the ATK inhibitor Ipatercertib in pTEN altered CRPC. A positive R3 trial in the ESMO plenary session. 2020-09-2025 minThe UromigosEpisode 58: Brilliant ESMO discussant Richard Cathomas talks to Brian and Tom about the meaning of DANUBE and KN362The group go into the detail of chemo immune combinations and what to do next. 2020-09-1926 minThe UromigosEpisode 57: Toni Choueiri - cabo & nivo vs sunitinib in metastatic clear cell renal cancerThe group attempts to put the data into context with the other available combinations.2020-09-1926 minThe UromigosEpisode 56: Matt Galsky and Tom Powles discuss ESMO 2020 immune therapy data in bladder cancerThe group try to get to the bottom of whether these data has made any difference in treatment and future plans. 2020-09-1927 minThe UromigosEpisode 55: The Uromigos Paper of the Month - Cabozantinib in Bladder Cancer by Dr. Andrea ApoloAndrea talks about her phase 2 trial which shows activity for Cabozantinib in urothelial cancer. 2020-08-3123 minThe UromigosEpisode 51: The Uromigos World Tour is in Norway with Jan Oldenburg - discussing key topics in testis cancerJan Oldenburg from Norway discusses treatment choices for stage 1 testis cancer, the dilemma of high dose therapy for relapse and long term toxicity of chemotherapy. 2020-07-1822 minThe UromigosEpisode 50: The Uromigos World Tour in London with renal cancer surgeryAxel Bex talks about small renal masses, robotic vs partial nephrectomy and surgery in metastatic disease. 2020-07-1522 minThe UromigosEpisode 46: The Uromigos World Tour in Spain discussing SOGUG and Renal Cancer with Cristina SuarezCristina Suarez discusses the success of clinical trials in Spain, and access to treatments. 2020-07-0919 minThe UromigosEpisode 45: The Uromigos World Tour arrives in JapanYoshi Tomita explains treatment pathways and research in GU cancer in Japan. Brian explains why he likes Japan so much. 2020-07-0320 minThe UromigosEpisode 44: The Uromigos World Tour in Australia - Talking with Ian Davis about prostate cancer and ANZUPIan Davis discusses why ANZUP has been so successful, and the EnzaMet study. An uninvited guest arrives towards the end. 2020-07-0331 minThe UromigosEpisode 43: The Uromigos World Tour in Singapore with Ravi KanesvaranRavi describes treatment pathways and research for Southeast Asia in GU cancer. 2020-06-2918 minThe UromigosEpisode 42: The Uromigos in ArgentinaJuan Sade discusses research, treatment pathways in GU cancer, steak and red wine in Argentina. 2020-06-2812 minThe UromigosEpisode 41: The Uromigos World Tour lands in Brazil - Fernando Maluf talks about prostate cancer and recent research in BrazilThe tour lands in sunny Brazil with a trip to a Japanese restaurant and a discussion about research and prostate cancer. 2020-06-2524 minThe UromigosEpisode 40: The Uromigos World Tour moves to France - Bernard Escudier discusses 2nd line therapy in renal cancer and TivozanibThe Uromigos World Tour moves to Paris. Treatment for tumours that progress after first line immunetherapy is discussed. The role of Tivozanib is a focus for the dialogue. 2020-06-2220 minThe UromigosEpisode 39: The Uromigos World Tour - Renal Cancer and IMDC Risk with Danny Heng in CalgaryDanny discusses Italian food and the past, present and future of the IMDC prognostic score. 2020-06-1820 minThe UromigosEpisode 38: The Uromigos Virtual World Tour - starting in Vancouver with Atezolizumab in NMIBCPeter Black talks about his recent BCG refractory NMIBC ASCO presentation and its implications for the field. 2020-06-1620 minThe UromigosEpisode 21: Treating cancer patients over the next year in the era of COVID-19The Uromigos struggle to describe what cancer care looks like in three months’ time during the COVID-19 pandemic.2020-04-1512 minThe UromigosEpisode 20: Treating GU Cancer Patients with acute COVID-19 InfectionThe Uromigos can’t agree on how to approach COVID-infected GU cancer patients who need systematic treatment.2020-04-1513 minThe UromigosEpisode 15: COVID-19 and Bladder Cancer SurgeryThe Uromigos discuss the practicalities in surgery for bladder cancer in the era of COVID-19 with Betsy Plimack (Fox Chase Cancer Center, Philadelphia)2020-03-2814 minThe UromigosEpisode 7: The First Uromigos Prostate Cancer PodcastSilke Gillessen and Chris Sweeney discuss how data from recent ESMO and GU ASCO meetings has changed the way they treat prostate cancer. 2020-02-2725 min
The UromigosEpisode 1: Introduction to Uromigos PodcastsProfessor Tom Powles and Dr. Brian Rini discuss the purpose of the podcasts and how to complain if you don’t like them2020-02-1103 min